A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and …
D Jenkins - Gynecologic oncology, 2008 - Elsevier
Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of invasive
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and …
D Jenkins - 2008 - cabidigitallibrary.org
Abstract Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of
invasive cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
invasive cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and …
D Jenkins - Gynecologic Oncology, 2008 - gynecologiconcology-online.net
Abstract Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of
invasive cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
invasive cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and …
D Jenkins - Gynecologic Oncology, 2008 - europepmc.org
Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of invasive
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and …
D Jenkins - Gynecologic Oncology, 2008 - infona.pl
Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of invasive
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
[引用][C] A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical …
D JENKINS - Gynecol Oncol, 2008 - cir.nii.ac.jp
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted
cervical cancer vaccine : importance of virological and clinical endpoints and implications for …
cervical cancer vaccine : importance of virological and clinical endpoints and implications for …
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and …
D Jenkins - Gynecologic oncology, 2008 - pubmed.ncbi.nlm.nih.gov
Human papilloma virus (HPV)-16 and-18 are responsible for approximately 70% of invasive
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …
cervical cancers worldwide. Other oncogenic HPV types account for almost all the …